4Terrault N A. ,Zhou Shuan, Combs Connie, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology, 1996,1 (24) : 1328.
5Nilufar Partovi,Miehelle W Guy,Mary H H Ensom, et al. A study of the pharmacokinetie Prole of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection. American Journal of Transplanatation, 2001, (1) : 51.
6Volker, Konig, Uwe, Hopf, et al. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation, 1994,58 ( 5 ) : 553.
7Saab S, Ham MY, Stone MA, et al. Decision analysis mo- del for hepatitis B prophylaxis one year after liver trans- plantation[J]. Liver Transpl, 2009,15 (4) : 413.
8Buti M, Mas A, Prieto M, et al. Adherence to lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hep- atitis B virus recurrence[J]. Transplantation, 2007,84(5) : 650.
9Lo CM, Cheung CK, Lau GK,et al. Significance of hepa- titis B virus genotype in liver transplantation for chronic hepatitis B[J]. Am J Transplant, 2005,5 (8) : 1 893.
10Yasunaka T, Takaki A, Yagi T, et al. Serum hepatitis B vi- rus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis[J]. Hepatol lnt, 2011, 5 (4):918.
